PL2231598T3 - Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- PL2231598T3 PL2231598T3 PL08872697T PL08872697T PL2231598T3 PL 2231598 T3 PL2231598 T3 PL 2231598T3 PL 08872697 T PL08872697 T PL 08872697T PL 08872697 T PL08872697 T PL 08872697T PL 2231598 T3 PL2231598 T3 PL 2231598T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- same
- pharmaceutical compositions
- compositions containing
- novel
- Prior art date
Links
- MUMXDRRTIYLYMY-YJKCNMNRSA-N (Z)-[dodecyl-[6-(dodecylazaniumyl)hexyl]amino]-oxido-oxidoiminoazanium Chemical class CCCCCCCCCCCC[NH2+]CCCCCCN(CCCCCCCCCCCC)[N+](\[O-])=N\[O-] MUMXDRRTIYLYMY-YJKCNMNRSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0708604A FR2924713B1 (en) | 2007-12-11 | 2007-12-11 | NOVEL DIAZENIUMDIOLATE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| PCT/FR2008/001716 WO2009103875A1 (en) | 2007-12-11 | 2008-12-10 | Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| EP08872697A EP2231598B1 (en) | 2007-12-11 | 2008-12-10 | Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2231598T3 true PL2231598T3 (en) | 2011-12-30 |
Family
ID=39158541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08872697T PL2231598T3 (en) | 2007-12-11 | 2008-12-10 | Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8288433B2 (en) |
| EP (1) | EP2231598B1 (en) |
| JP (1) | JP5247814B2 (en) |
| KR (1) | KR20100083195A (en) |
| CN (1) | CN101910128B (en) |
| AR (1) | AR069643A1 (en) |
| AT (1) | ATE520658T1 (en) |
| AU (1) | AU2008351147B2 (en) |
| BR (1) | BRPI0822066A2 (en) |
| CA (1) | CA2707853C (en) |
| DK (1) | DK2231598T3 (en) |
| EA (1) | EA201000885A1 (en) |
| ES (1) | ES2371699T3 (en) |
| FR (1) | FR2924713B1 (en) |
| GE (1) | GEP20135733B (en) |
| HR (1) | HRP20110755T1 (en) |
| MA (1) | MA31901B1 (en) |
| MX (1) | MX2010006446A (en) |
| MY (1) | MY147973A (en) |
| NZ (1) | NZ586070A (en) |
| PL (1) | PL2231598T3 (en) |
| PT (1) | PT2231598E (en) |
| RS (1) | RS52001B (en) |
| SI (1) | SI2231598T1 (en) |
| UA (1) | UA97035C2 (en) |
| WO (1) | WO2009103875A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011053519A1 (en) * | 2009-10-29 | 2011-05-05 | Merck Sharp & Dohme Corp. | Diuretics |
| CN102883610A (en) | 2010-02-12 | 2013-01-16 | 默沙东公司 | Diazeniumdiolate cyclopentyl derivatives |
| EP2571351B1 (en) * | 2010-05-21 | 2016-09-14 | Merck Sharp & Dohme Corp. | Diazeniumdiolate cyclohexyl derivatives |
| BR112013009389A2 (en) | 2010-10-29 | 2017-10-31 | Merck Sharp & Dohme | diazene diolate-derived heterocyclic compound and pharmaceutical composition |
| JO3350B1 (en) | 2011-03-07 | 2019-03-13 | Merck Sharp & Dohme | Heterocyclic derivatives containing primary amino groups and diazeniumdiolates |
| EP2704568B1 (en) | 2011-05-02 | 2018-01-24 | Merck Sharp & Dohme Corp. | Diazeniumdiolate cyclohexyl derivatives |
| CN109608371B (en) * | 2019-01-16 | 2020-12-29 | 泰州学院 | O2-4-(3-(4-Sulfamoylphenyl)urea)phenylazonium diolate derivatives, preparation method and use |
| CN114805183B (en) * | 2022-05-07 | 2022-12-27 | 武汉科技大学 | NO donor type piperlongumine derivatives, preparation method and application |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1203691A (en) * | 1968-03-06 | 1970-09-03 | Science Union & Cie | New disubstituted n-amino indoline derivatives and process for preparing them |
| JPH0233030B2 (en) * | 1982-01-18 | 1990-07-25 | Mitsui Toatsu Chemicals | SURUFUAMOIRUANSOKUKOSANJUDOTAIOYOBISOREOJUKOSEIBUNTOSHITEFUKUMUCHIRYOYOSOSEIBUTSU |
| JPH07118231A (en) * | 1993-10-22 | 1995-05-09 | Nippon Oil & Fats Co Ltd | Sulfamoylbenzoic acid derivative |
| US5958427A (en) * | 1996-11-08 | 1999-09-28 | Salzman; Andrew L. | Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| AUPS236902A0 (en) * | 2002-05-16 | 2002-06-13 | Northern Sydney Area Health Service | Composition and method for treating hypertension |
| AU2005306629A1 (en) * | 2004-11-15 | 2006-05-26 | Nicox S.A. | Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use |
| EP1855688A4 (en) * | 2005-02-24 | 2011-09-14 | Nicox Sa | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| US7947664B2 (en) * | 2008-01-24 | 2011-05-24 | Merck Sharp & Dohme Corp. | Angiotensin II receptor antagonists |
| WO2009099853A2 (en) * | 2008-02-08 | 2009-08-13 | Merck & Co., Inc. | Angiotensin ii receptor antagonists |
-
2007
- 2007-12-11 FR FR0708604A patent/FR2924713B1/en not_active Expired - Fee Related
-
2008
- 2008-12-10 PL PL08872697T patent/PL2231598T3/en unknown
- 2008-12-10 MX MX2010006446A patent/MX2010006446A/en active IP Right Grant
- 2008-12-10 BR BRPI0822066A patent/BRPI0822066A2/en not_active IP Right Cessation
- 2008-12-10 HR HR20110755T patent/HRP20110755T1/en unknown
- 2008-12-10 PT PT08872697T patent/PT2231598E/en unknown
- 2008-12-10 UA UAA201008615A patent/UA97035C2/en unknown
- 2008-12-10 AT AT08872697T patent/ATE520658T1/en active
- 2008-12-10 EA EA201000885A patent/EA201000885A1/en unknown
- 2008-12-10 AU AU2008351147A patent/AU2008351147B2/en not_active Ceased
- 2008-12-10 WO PCT/FR2008/001716 patent/WO2009103875A1/en not_active Ceased
- 2008-12-10 KR KR1020107012930A patent/KR20100083195A/en not_active Abandoned
- 2008-12-10 DK DK08872697.1T patent/DK2231598T3/en active
- 2008-12-10 JP JP2010537487A patent/JP5247814B2/en not_active Expired - Fee Related
- 2008-12-10 US US12/735,048 patent/US8288433B2/en not_active Expired - Fee Related
- 2008-12-10 GE GEAP200811874A patent/GEP20135733B/en unknown
- 2008-12-10 CN CN2008801229307A patent/CN101910128B/en not_active Expired - Fee Related
- 2008-12-10 ES ES08872697T patent/ES2371699T3/en active Active
- 2008-12-10 EP EP08872697A patent/EP2231598B1/en active Active
- 2008-12-10 RS RS20110438A patent/RS52001B/en unknown
- 2008-12-10 SI SI200830404T patent/SI2231598T1/en unknown
- 2008-12-10 CA CA2707853A patent/CA2707853C/en not_active Expired - Fee Related
- 2008-12-10 MY MYPI2010002633A patent/MY147973A/en unknown
- 2008-12-10 NZ NZ586070A patent/NZ586070A/en not_active IP Right Cessation
- 2008-12-11 AR ARP080105371A patent/AR069643A1/en not_active Application Discontinuation
-
2010
- 2010-06-07 MA MA32894A patent/MA31901B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101910128A (en) | 2010-12-08 |
| EA201000885A1 (en) | 2011-02-28 |
| FR2924713A1 (en) | 2009-06-12 |
| AU2008351147B2 (en) | 2012-04-12 |
| AR069643A1 (en) | 2010-02-10 |
| DK2231598T3 (en) | 2011-12-05 |
| SI2231598T1 (en) | 2011-11-30 |
| WO2009103875A1 (en) | 2009-08-27 |
| NZ586070A (en) | 2012-06-29 |
| MA31901B1 (en) | 2010-12-01 |
| UA97035C2 (en) | 2011-12-26 |
| ATE520658T1 (en) | 2011-09-15 |
| RS52001B (en) | 2012-04-30 |
| KR20100083195A (en) | 2010-07-21 |
| CA2707853C (en) | 2013-02-05 |
| HRP20110755T1 (en) | 2011-11-30 |
| PT2231598E (en) | 2011-10-11 |
| GEP20135733B (en) | 2013-01-25 |
| CA2707853A1 (en) | 2009-08-27 |
| BRPI0822066A2 (en) | 2015-09-22 |
| US8288433B2 (en) | 2012-10-16 |
| EP2231598B1 (en) | 2011-08-17 |
| US20100286225A1 (en) | 2010-11-11 |
| FR2924713B1 (en) | 2010-01-29 |
| ES2371699T3 (en) | 2012-01-09 |
| JP5247814B2 (en) | 2013-07-24 |
| CN101910128B (en) | 2013-01-16 |
| MY147973A (en) | 2013-02-28 |
| JP2011506408A (en) | 2011-03-03 |
| AU2008351147A1 (en) | 2009-08-27 |
| MX2010006446A (en) | 2010-07-05 |
| EP2231598A1 (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| IL208203A (en) | 2,3-dihydro-pyrido-1,4-oxazine and 2,3-dihydro-4-oxa-1,9-diazaphenanthrene derivatives, processes for their preparation and pharmaceutical compositions comprising them | |
| PL2036892T3 (en) | 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL185353A0 (en) | Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof | |
| PT2364983E (en) | Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same | |
| IL204521A0 (en) | Oxadiazole derivatives, their preparation and pharmaceutical compositions containing them | |
| ZA200903160B (en) | Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals | |
| IL206808A (en) | Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof | |
| IL192826A0 (en) | Thiazole derivatives, their preparation and pharmaceutical compositions containing them | |
| IL200206A (en) | Quinoxaline derivatives, their preparation and pharmaceutical compositions containing them | |
| EP1841761A4 (en) | Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same | |
| PL1752443T3 (en) | New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it | |
| IL218539A (en) | N-substituted 1,4-androstadiene 3-oxo-6,9-dihalo-16-isoxazolidine-17-acyl derivatives, processes for their preparation, pharmaceutical compositions comprising them and uses thereof | |
| IL213452A0 (en) | Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | |
| PT2231598E (en) | Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
| IL186062A0 (en) | Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| TWI315305B (en) | Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof | |
| EP1916251A4 (en) | Erianin salts, their preparation methods and pharmaceutical compositions containing the same | |
| ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| ZA200806399B (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
| IL213792A0 (en) | Novel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing the same and method for preparing the same | |
| IL213588A0 (en) | Naphthyridine derivatives, their preparation and pharmaceutical compositions containing them | |
| IL199254A (en) | Aminoguanidine derivatives, pharmaceutical compositions comprising them, process for their preparation and use thereof | |
| IL206936A0 (en) | 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same |